149 related articles for article (PubMed ID: 38701269)
21. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis.
Dai W; Ye L; Liu A; Wen SW; Deng J; Wu X; Lai Z
Medicine (Baltimore); 2017 Sep; 96(39):e8179. PubMed ID: 28953675
[TBL] [Abstract][Full Text] [Related]
22. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
Kwon OY; Choi JY; Jang Y
J Med Internet Res; 2023 Jan; 25():e37487. PubMed ID: 36689264
[TBL] [Abstract][Full Text] [Related]
23. Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis.
Shen SS; Gong JJ; Wang XW; Chen L; Qin S; Huang LF; Chen YQ; Ren H; Yang QB; Hu HD
Turk J Gastroenterol; 2017 Jan; 28(1):31-39. PubMed ID: 27991855
[TBL] [Abstract][Full Text] [Related]
24. Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Pan B; Cai J; Zhao P; Liu J; Fu S; Jing G; Niu Q; Li Q
Osteoporos Int; 2022 Nov; 33(11):2275-2286. PubMed ID: 35764892
[TBL] [Abstract][Full Text] [Related]
25. Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis.
Kong T; Gu Y; Sun L; Zhou R; Li J; Shi J
Endocr J; 2023 Oct; 70(10):959-967. PubMed ID: 37468264
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta-analysis.
Xue J; Xin H; Ren N; Zhou C; Yang J; Song L; Qin S
Eur J Clin Invest; 2019 Sep; 49(9):e13158. PubMed ID: 31338830
[TBL] [Abstract][Full Text] [Related]
27. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
[TBL] [Abstract][Full Text] [Related]
28. Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease: A Systematic Review and Meta-analysis.
Chen TL; Lee LL; Huang HK; Wang JH; Chen LY; Tsai HR; Loh CH; Chi CC
JAMA Dermatol; 2022 Jan; 158(1):59-67. PubMed ID: 34851364
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
[TBL] [Abstract][Full Text] [Related]
30. Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis.
Deng C; Ou Q; Ou X; Pan D
BMJ Open; 2024 May; 14(5):e078933. PubMed ID: 38719326
[TBL] [Abstract][Full Text] [Related]
31. Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis.
Saokaew S; Kanchanasurakit S; Thawichai K; Duangprom P; Wannasri M; Khankham S; Kositamongkol C; Chaiyakunapruk N; Phisalprapa P
Medicine (Baltimore); 2021 Feb; 100(5):e24557. PubMed ID: 33592910
[TBL] [Abstract][Full Text] [Related]
32. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis.
Jagirdhar GSK; Qasba RK; Pattnaik H; Rama K; Banga A; Reddy ST; Flumignan Bucharles AC; Kashyap R; Elmati PR; Bansal V; Bains Y; DaCosta T; Surani S
World J Gastroenterol; 2023 Jun; 29(21):3362-3378. PubMed ID: 37377589
[TBL] [Abstract][Full Text] [Related]
33. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic Fatty Liver Disease and Urolithiasis. A Systematic Review and Meta-Analysis.
Wijarnpreecha K; Lou S; Panjawatanan P; Sanguankeo A; Pungpapong S; Lukens FJ; Ungprasert P
J Gastrointestin Liver Dis; 2018 Dec; 27(4):427-432. PubMed ID: 30574625
[TBL] [Abstract][Full Text] [Related]
35. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.
Li F; Ye J; Shao C; Zhong B
Lipids Health Dis; 2021 Feb; 20(1):22. PubMed ID: 33637088
[TBL] [Abstract][Full Text] [Related]
36. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
Bellinato F; Goio I; Malara G; Rosato A; Targher G; Girolomoni G; Gisondi P
J Cutan Med Surg; 2022; 26(3):249-255. PubMed ID: 34894782
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
de Vries M; Westerink J; Kaasjager KHAH; de Valk HW
J Clin Endocrinol Metab; 2020 Dec; 105(12):3842-53. PubMed ID: 32827432
[TBL] [Abstract][Full Text] [Related]
38. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.
Abedini R; Salehi M; Lajevardi V; Beygi S
Clin Exp Dermatol; 2015 Oct; 40(7):722-7. PubMed ID: 25958919
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease: Possible relationship from an updated meta-analysis.
Liu C; Wu Q; Ren R; Zhang Z; Shi Y; Li H
Medicine (Baltimore); 2023 Aug; 102(33):e34605. PubMed ID: 37603516
[TBL] [Abstract][Full Text] [Related]
40. Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis.
Yang J; Zhang K; Xi Z; Ma Y; Shao C; Wang W; Tang YD
Sleep Breath; 2023 Oct; 27(5):1985-1996. PubMed ID: 36544011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
